Overview

The rapid evolution of drug development and technology, coupled with regulatory advances have created new opportunities and challenges in healthcare. It is critical for regulators, academia, patients, and industries to collaborate closely to ensure an evolving and robust regulatory ecosystem that enables accelerated and cost-effective access to innovative healthcare solutions. This year, DIA Singapore Annual Meeting aims to bring regulators, patient representatives and industries to share and discuss ways in cultivating synergies in clinical research and the regulatory environment to innovate healthcare in APAC. Come join us and be a part of the discussions to explore the challenges and actions that stakeholders in APAC can adopt to ensure transformations in the healthcare evolution.

View Program

Featured

Want to learn more about 2024 DIA Singapore Annual Meeting? You've come to the right site!

Exhibits

Learn more

Exhibits

Learn more

Learning objectives

• Receive updates from senior regulators how healthcare products are regulated, what actions/ plans they have for regulating innovative products and clinical trials, and their collaborations with key stakeholders.

• Hear the dialogues between regulators, patient representatives and industries on Clinical Research and the Product Registration topics.

• Receive the information on hot regulatory topics, such as ICH guidelines, AI, and new technologies adopted in R&D.

• ASEAN Townhall: Hear deliberation about the topics discussed at this DIA Singapore from the ASEAN countries regulators.

• Network with regulators, patient representatives, clinical development, pharmacovigilance and regulatory affairs professionals from industries.

Program Committee

Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore
Helene Sou, MSc, RAC Global Regulatory Policy and Innovation
Takeda Pharmaceutical Company Limited., Singapore
Audrey Ooi, MSc Head- Business Development
Clinical Research Malaysia, Malaysia
Ellyne Setiawan, MPharm Head of Research & Development Quality (Asia Pacific),
Daiichi Sankyo Singapore Pte. Ltd., Singapore
Jack Wong Founder
ARPA (Asia Regulatory Professionals Association) , Singapore
Martin Lim, MBA, MS Co-Founder and CEO
ONWARD Health Research, Singapore
Sannie S Foong Chong, PhD Senior Director, Global Regulatory Policy
MSD International, Singapore
Senthil Sockalingam Head of Medical Affairs, APAC
BeiGene, Singapore
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore
Vicky Hsu Senior Vice President, Head of Project Leadership and Biotech Operations Asia
Parexel International, Singapore
Shogo Nakamori, MBA, MSc, RPh Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore
DIA, Japan
Jing Ping Yeo, PhD Global Head, Project Operations & Head, Transformation
George Clinical, Singapore
Fengyun (Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
Seasea GAO, MD, PhD Executive Medical Director
JAPAC Merck, Singapore